171 related articles for article (PubMed ID: 35745769)
1. siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells.
Pengnam S; Charoensuksai P; Yingyongnarongkul BE; Saeeng R; Uludağ H; Patrojanasophon P; Opanasopit P; Plianwong S
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745769
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
Tohkayomatee R; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 May; 27(11):. PubMed ID: 35684480
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
[TBL] [Abstract][Full Text] [Related]
4. Co-Delivery of Gemcitabine and Mcl-1 SiRNA via Cationic Liposome-Based System Enhances the Efficacy of Chemotherapy in Pancreatic Cancer.
Wang Y; Gao F; Jiang X; Zhao X; Wang Y; Kuai Q; Nie G; He M; Pan Y; Shi W; Ren S; Yu Q
J Biomed Nanotechnol; 2019 May; 15(5):966-978. PubMed ID: 30890228
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids.
Pengnam S; Plianwong S; Patrojanasophon P; Radchatawedchakoon W; Yingyongnarongkul BE; Opanasopit P; Charoensuksai P
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33919902
[TBL] [Abstract][Full Text] [Related]
6. Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.
Santadkha T; Skolpap W; K C R; Ansari A; Kucharski C; Atz Dick T; Uludağ H
Invest New Drugs; 2022 Oct; 40(5):962-976. PubMed ID: 35834040
[TBL] [Abstract][Full Text] [Related]
7. Targeted silencing of the MCL-1 gene using multi-layered dendrimer-based nanoconstructs achieves efficient tumor regression in xenografted mice models.
Tambe P; Salve R; Choudhary P; Kumar P; Jadhav S; Paknikar KM; Gajbhiye V
Int J Pharm; 2023 Mar; 634():122659. PubMed ID: 36720446
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1.
Wu H; Schiff DS; Lin Y; Neboori HJ; Goyal S; Feng Z; Haffty BG
Radiat Res; 2014 Dec; 182(6):618-25. PubMed ID: 25409124
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors.
Zhou W; Hu J; Tang H; Wang D; Huang X; He C; Zhu H
BMC Cancer; 2011 Nov; 11():485. PubMed ID: 22078414
[TBL] [Abstract][Full Text] [Related]
10. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
Aliabadi HM; Mahdipoor P; Uludağ H
Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
[TBL] [Abstract][Full Text] [Related]
11. Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis.
Jada SR; Matthews C; Saad MS; Hamzah AS; Lajis NH; Stevens MF; Stanslas J
Br J Pharmacol; 2008 Nov; 155(5):641-54. PubMed ID: 18806812
[TBL] [Abstract][Full Text] [Related]
12. Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells.
Sanz Del Olmo N; Holota M; Michlewska S; Gómez R; Ortega P; Ionov M; de la Mata FJ; Bryszewska M
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32748821
[TBL] [Abstract][Full Text] [Related]
13. Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.
Plianwong S; Thapa B; Kc RB; Kucharski C; Rojanarata T; Uludağ H
Pharm Res; 2020 Feb; 37(3):46. PubMed ID: 32016611
[TBL] [Abstract][Full Text] [Related]
14. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
Thapa B; Bahadur Kc R; Uludağ H
Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
[TBL] [Abstract][Full Text] [Related]
15. [Silencing RRM1 gene reverses paclitaxel resistance in human breast cancer cell line MCF- 7/R by inducing cell apoptosis].
Tian N; Zhou L; Yang D; Wu H; Ma Y; Lü L; Wu S
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):304-312. PubMed ID: 31068300
[TBL] [Abstract][Full Text] [Related]
16. Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA.
Chang RS; Suh MS; Kim S; Shim G; Lee S; Han SS; Lee KE; Jeon H; Choi HG; Choi Y; Kim CW; Oh YK
Biomaterials; 2011 Dec; 32(36):9785-95. PubMed ID: 21937102
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer.
Zuo J; Jiang Y; Zhang E; Chen Y; Liang Z; Zhu J; Zhao Y; Xu H; Liu G; Liu J; Wang W; Zhang S; Zhen Y
Life Sci; 2019 Jun; 227():145-152. PubMed ID: 31009625
[TBL] [Abstract][Full Text] [Related]
18. Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.
Aliabadi HM; Maranchuk R; Kucharski C; Mahdipoor P; Hugh J; Uludağ H
J Control Release; 2013 Nov; 172(1):219-228. PubMed ID: 23994345
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells.
Shen Y; Du Y; Zhang Y; Pan Y
Mol Med Rep; 2015 Jul; 12(1):456-62. PubMed ID: 25738757
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]